praziquantel has been researched along with Cirrhosis, Liver in 73 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of repeated application of praziquantel in the treatment of hepatic fibrosis due to schistosomiasis." | 9.22 | [Efficacy of repeated application of praziquantel in treatment of hepatic fibrosis due to schistosomiasis]. ( Hong-Bao, L; Ming, S, 2016) |
| "Five hundred thirty six Sudanese schoolchildren with Schistosoma mansoni infection were treated at random with either 20 mg or 40 mg/kg praziquantel." | 9.07 | Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. ( Abdalla, M; Abdel-Rahim, IM; Doehring-Schwerdtfeger, E; Elsheikh, M; Franke, D; Kaiser, C; Kardorff, R; Mohamed-Ali, Q; Schafer, P; Schlake, J, 1991) |
| "To investigate the clinical therapeutic effect of biological information infrared liver therapeutic apparatus (BILT) combined with praziquantel in the treatment of patients with chronic schistosomiasis." | 7.85 | [Therapeutic effect of BILT combined with praziquantel in treatment of chronic schistosomiasis]. ( Hong-Bo, W; Li-le, L; Na, Z; Ni-Na, P; Ru-Yi, L; Yan, M; Yu, H, 2017) |
| "To study the therapeutical effect and mechanisms of resveratrol and its combination with praziquantel on the liver fibrosis due to Schistosoma japonicum infection." | 7.79 | [Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice]. ( Chen, Y; Xiao, Z, 2013) |
| "Colchicine treated mice showed significant decrease in prevalence of fibrocellular and fibrocellular and fibrous granulomas in liver specimens compared to corresponding control groups." | 7.69 | Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice. ( el-Monayerhy, MS; Fahmy, IA; Montasser, MF; Rashad, MS; Sabry, NM; Younis, TA, 1994) |
| " The effect of treatment with praziquantel at 8, 12, and 20 weeks postinfection on fibrosis was assessed by determination of total hepatic collagen content, ratio of type III/I + III collagen, granuloma volume, and histopathological examination of liver section." | 7.67 | Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni. ( Abdallah, NM; Botros, SS; el-Badrawy, NM; Hassanein, HI; Herbage, D; Nagy, FM, 1988) |
| "mansoni) induced liver fibrosis." | 5.48 | Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. ( El-Sayed, SH; Mahmoud, SS; Negm, MSI; Raafat, A; Rizk, EMA; Sobhy, MMK, 2018) |
| "To evaluate the efficacy of repeated application of praziquantel in the treatment of hepatic fibrosis due to schistosomiasis." | 5.22 | [Efficacy of repeated application of praziquantel in treatment of hepatic fibrosis due to schistosomiasis]. ( Hong-Bao, L; Ming, S, 2016) |
| "Five hundred thirty six Sudanese schoolchildren with Schistosoma mansoni infection were treated at random with either 20 mg or 40 mg/kg praziquantel." | 5.07 | Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. ( Abdalla, M; Abdel-Rahim, IM; Doehring-Schwerdtfeger, E; Elsheikh, M; Franke, D; Kaiser, C; Kardorff, R; Mohamed-Ali, Q; Schafer, P; Schlake, J, 1991) |
| "The pharmacokinetics and therapeutic efficacy of praziquantel (Distocide; Epico, El-Asher-Men-Ramadan City, Egypt) were studied in 40 patients with schistosomiasis mansoni and various degrees of hepatic dysfunction." | 5.07 | Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure. ( Abdel-Bary, MA; Abdel-Fatah, SA; el Guiniady, MA; el Touny, MA; Metwally, A, 1994) |
| "These findings suggest that in order to reverse moderate to severe liver fibrosis due to schistosomiasis and improve clinical outcomes, a higher clinical dosage of praziquantel (i." | 3.85 | Biennial versus annual treatment for schistosomiasis and its impact on liver morbidity. ( Guevarra, JR; Harn, DA; Inobaya, MT; Lam, AK; Li, Y; McManus, DP; Ng, SK; Olveda, DU; Olveda, RM; Ross, AG; Vinluan, ML, 2017) |
| "To investigate the clinical therapeutic effect of biological information infrared liver therapeutic apparatus (BILT) combined with praziquantel in the treatment of patients with chronic schistosomiasis." | 3.85 | [Therapeutic effect of BILT combined with praziquantel in treatment of chronic schistosomiasis]. ( Hong-Bo, W; Li-le, L; Na, Z; Ni-Na, P; Ru-Yi, L; Yan, M; Yu, H, 2017) |
| "To assess whether schistosomiasis coinfection with chronic hepatitis C virus (HCV) influences hepatic fibrosis and pegylated-interferon/ribavirin (PEG-IFN/RIB) therapy response." | 3.79 | Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. ( Abdel-Rahman, M; El Raziky, M; El-Akel, W; El-Sayed, M; Elsharkawy, A; Esmat, G; Ghoneim, H; Khattab, H, 2013) |
| "To explore the value of B-ultrasound on the evaluation of the effects of traditional Chinese medicine compound of Radix astragali, Salvia miltiorrhiza and Angelica sinensis, and TCM + praziquantel on liver fibrosis in rabbits with schistosomiasis." | 3.79 | Effect of Chinese herbal compound on liver fibrosis in rabbits with schistosomiasis by B-ultrasound. ( Liang, XL; Yuan, JY, 2013) |
| "To study the therapeutical effect and mechanisms of resveratrol and its combination with praziquantel on the liver fibrosis due to Schistosoma japonicum infection." | 3.79 | [Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice]. ( Chen, Y; Xiao, Z, 2013) |
| "To evaluate the effect of rosiglitazone in a murine model of liver fibrosis induced by Schistosoma japonicum infection." | 3.74 | Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. ( Chen, H; He, YW; Liu, WQ; Zhang, JH, 2008) |
| "Colchicine treated mice showed significant decrease in prevalence of fibrocellular and fibrocellular and fibrous granulomas in liver specimens compared to corresponding control groups." | 3.69 | Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice. ( el-Monayerhy, MS; Fahmy, IA; Montasser, MF; Rashad, MS; Sabry, NM; Younis, TA, 1994) |
| " The effect of treatment with praziquantel at 8, 12, and 20 weeks postinfection on fibrosis was assessed by determination of total hepatic collagen content, ratio of type III/I + III collagen, granuloma volume, and histopathological examination of liver section." | 3.67 | Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni. ( Abdallah, NM; Botros, SS; el-Badrawy, NM; Hassanein, HI; Herbage, D; Nagy, FM, 1988) |
| "Schistosomiasis is a prevalent parasitic disease worldwide." | 2.61 | The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis. ( Chen, H; Chen, Q; Gong, Q; Nie, H; Zhang, J; Zheng, B; Zheng, T, 2019) |
| "In China, only schistosomiasis japonica is transmitted." | 2.52 | Research and control of advanced schistosomiasis japonica in China. ( Feng, A; Huang, Y; Wu, W, 2015) |
| "Liver fibrosis is the main cause of death in the 20 millions individuals suffering from chronic schistosomosis." | 2.41 | [Schistosoma mansoni schistosomiasis]. ( Dessein, A; Ranque, S, 2001) |
| "Schistosoma mansoni liver fibrosis is a complicated multicellular process involving numerous cytokines, chemokines, and growth factors." | 1.72 | Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice. ( Abd Allah, MH; Abo-Sheishaa, GA; Bayoumy, AS; Shalash, IR; Zaalouk, TK, 2022) |
| "Although the pathogenesis of liver fibrosis has been intensively studied, the choice of effective treatment is still inadequate." | 1.72 | Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice. ( Chang, KC; Cheng, PC; Lam, HYP; Lan, YC; Liang, TR; Peng, SY, 2022) |
| "Praziquantel not only has broad-spectrum anti-trematode and anti-tapeworm effects, but also has pharmacological effects such as regulating inflammatory response and anti-fibrosis." | 1.62 | [Progress of researches on the actions of praziquantel against hepatic fibrosis]. ( Dai, JR; Yuan, X, 2021) |
| "Omeprazole is a proton pump inhibitor which is reported to have antiparasitic properties." | 1.51 | Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice. ( Abdel Ghaffar, AE; Alshenawy, HA; Elgendy, DI; Ellakany, AR, 2019) |
| "PZQ exhibited a strong efficacy against liver fibrosis by inhibiting activation of HSCs via Smad7 up-regulation, suggesting potential broad utility in treatment of diseases characterized by liver fibrosis." | 1.51 | Praziquantel ameliorates CCl ( Kong, D; Liu, J; Liu, X; Lu, Z; Qiu, J; Wang, Y; Xie, Y; Zhang, R; Zhou, C, 2019) |
| "Liver fibrosis is an important process that occurs in most types of chronic liver diseases and often results in the end stage of liver diseases, such as cirrhosis, portal hypertension, and hepatocellular carcinoma." | 1.48 | Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice. ( Chen, Y; Dong, H; Liu, X; Ma, Z; Wang, L; Xia, D; Xiong, Y, 2018) |
| " CONCLUSIONS Our findings suggest that the treatment using APS-1 in combination with praziquantel attenuated S." | 1.48 | A Polysaccharide from Amusium Pleuronectes Combined with Praziquantel Treatment Ameliorates Hepatic Fibrosis in Schistosoma Japonicum-Infected Mice. ( Hu, W; Jiang, Y; Lv, Y; Sun, T; Tang, X; Zhan, X; Zhang, W; Zhou, S, 2018) |
| "mansoni) induced liver fibrosis." | 1.48 | Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. ( El-Sayed, SH; Mahmoud, SS; Negm, MSI; Raafat, A; Rizk, EMA; Sobhy, MMK, 2018) |
| "Liver fibrosis is the main pathology of schistosomiasis and its complications are the major cause of death in infected cases." | 1.46 | Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment. ( Brakat, RM; Mohamed, ASED; Sharaf El-Deen, SA, 2017) |
| "Liver fibrosis was reduced significantly evidenced by reduced hydroxyproline levels [P<0." | 1.46 | Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis. ( Ashour, RH; Elhenawy, AA; Megahed, N; Nabih, N; Shalaby, NM, 2017) |
| "mansoni)-induced liver fibrosis in mice." | 1.43 | Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice. ( Eissa, MM; Elatrebi, SF; Elsakkar, MG; Hewedy, WA; Nassra, RM, 2016) |
| "Regression of S." | 1.43 | Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis. ( Abdelsalam, RM; Attia, YM; El-Khatib, AS; Elkhafif, N; Elmazar, MM; Hammam, OA; Kenawy, SA; Mansour, MT, 2016) |
| "Schistomiasis was associated with hepatomegaly (adjusted prevalence ratio [aPR] = 1." | 1.42 | Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya. ( Davis, SM; Fox, LM; Harris, R; Kareko, EI; Mulama, F; Mwinzi, PM; Ochola, E; Odiere, MR; Rawago, F; Samuels, AM; Wiegand, RE; Won, KY, 2015) |
| " All 8 animals were treated under anaesthesia by oral gavage with PZQ at 60 mg/kg dosing that was well tolerated." | 1.39 | Intestinal schistosomiasis in chimpanzees on Ngamba Island, Uganda: observations on liver fibrosis, schistosome genetic diversity and praziquantel treatment. ( Adriko, M; Ajarova, L; Arinaitwe, M; Betson, M; Kabatereine, NB; Mopya, S; Mugisha, L; Rukundo, J; Standley, CJ; Stothard, JR, 2013) |
| "Hepatic schistosomiasis is a well recognized cause of chronic liver disease and portal hypertension." | 1.38 | Incidental hepatic schistosomiasis in a liver transplant recipient. ( Ariza-Heredia, E; Razonable, RR, 2012) |
| "Praziquantel (PZQ) is an isoquinoline derivative (2-cyclohexylcarbonyl-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino{2,1-a}-isoquinoline-4-one), and is currently the drug of choice for all forms of schistosomiasis." | 1.38 | Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. ( Ain-Shoka, AA; Badawy, AA; Ebeid, FA; El-Lakkany, NM; El-Maadawy, WH; Hammam, OA, 2012) |
| "Its effect on the extent of liver fibrosis, through estimation of hepatic hydroxyproline and hepatic collagen content in liver hydrolysates, was also evaluated." | 1.38 | Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice. ( Ammar, EM; Elkashef, WF; Gameil, NM; Said, E; Said, SA, 2012) |
| "However, PZQ does not improve liver fibrosis." | 1.38 | Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice. ( Aabdel-Wahab, S; Abdel-Hafeez, EH; Abdulla, AM; Ahmad, AK; Mosalem, FA, 2012) |
| "Liver fibrosis was graded according to semi-quantitative scoring system (SSS) method." | 1.37 | [Effect of ginsenoside Rg3 on hepatic fibrosis in murine schistosomiasis japonica]. ( Jia, XM; Li, CY; Li, F; Wang, H; Zeng, J, 2011) |
| "Praziquantel treatment in Opisthorchis viverrini-infected patients reduces the hepatobiliary fibrosis due to tissue resorption, however, some fibroses are irreversible." | 1.35 | Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection. ( Boonmars, T; Hiraku, Y; Pinlaor, P; Pinlaor, S; Prakobwong, S; Wongkham, C, 2009) |
| "Effects of PTX on the content change of hepatic TGF-beta1, type I and type III collagen in schistosomiasis japonica mice with liver fibrosis were related to the dosage of PTX, high dose PTX treated group could significantly reduce the content of TGF-beta1 (0." | 1.32 | Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis. ( Cai, SQ; Luo, DD; Xiong, LJ; Zen, LL; Zhu, JF, 2003) |
| "Liver fibrosis was mild in all HTLV-1 coinfected patients and efficacy of praziquantel was lower in patients dually infected than in patients infected only with S." | 1.32 | HTLV-1 modifies the clinical and immunological response to schistosomiasis. ( Alcantara, L; Carvalho, EM; Gonzalez, D; Gonzalez, T; Guerreiro, JB; Ho, JL; Neva, F; Passos, J; Porto, AF; Santos, SB, 2004) |
| "Schistosomiasis mansoni is a tropical helminthic disease characterized by parasite egg-induced granulomatous inflammation and cumulative fibrosis." | 1.32 | Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. ( Boros, DL; Gerard, HC; Hudson, AP; Singh, KP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.85) | 18.7374 |
| 1990's | 11 (15.07) | 18.2507 |
| 2000's | 12 (16.44) | 29.6817 |
| 2010's | 39 (53.42) | 24.3611 |
| 2020's | 6 (8.22) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, X | 1 |
| Dai, JR | 1 |
| Abou Rayia, DM | 1 |
| Ashour, DS | 1 |
| Abo Safia, HS | 1 |
| Abdel Ghafar, MT | 1 |
| Amer, RS | 1 |
| Saad, AE | 1 |
| Abd Allah, MH | 1 |
| Zaalouk, TK | 1 |
| Abo-Sheishaa, GA | 1 |
| Shalash, IR | 1 |
| Bayoumy, AS | 1 |
| Dong, H | 3 |
| Zhao, L | 2 |
| Sun, H | 2 |
| Shang, M | 2 |
| Lv, G | 2 |
| Yu, X | 2 |
| Hu, B | 2 |
| Huang, Y | 3 |
| Liu, J | 1 |
| Kong, D | 1 |
| Qiu, J | 1 |
| Xie, Y | 1 |
| Lu, Z | 1 |
| Zhou, C | 2 |
| Liu, X | 2 |
| Zhang, R | 1 |
| Wang, Y | 2 |
| Mueller, A | 1 |
| Fuss, A | 1 |
| Ziegler, U | 1 |
| Kaatano, GM | 1 |
| Mazigo, HD | 1 |
| Ellakany, AR | 1 |
| Elgendy, DI | 1 |
| Alshenawy, HA | 1 |
| Abdel Ghaffar, AE | 1 |
| Chen, Q | 1 |
| Zhang, J | 1 |
| Zheng, T | 1 |
| Chen, H | 2 |
| Nie, H | 1 |
| Zheng, B | 1 |
| Gong, Q | 1 |
| Nono, JK | 1 |
| Fu, K | 1 |
| Mpotje, T | 1 |
| Varrone, G | 1 |
| Aziz, NA | 1 |
| Mosala, P | 1 |
| Hlaka, L | 1 |
| Kamdem, SD | 1 |
| Xu, D | 1 |
| Spangenberg, T | 1 |
| Brombacher, F | 1 |
| Lam, HYP | 1 |
| Liang, TR | 1 |
| Lan, YC | 1 |
| Chang, KC | 1 |
| Cheng, PC | 1 |
| Peng, SY | 1 |
| Elhenawy, AA | 1 |
| Ashour, RH | 1 |
| Nabih, N | 1 |
| Shalaby, NM | 1 |
| Megahed, N | 1 |
| Sharaf El-Deen, SA | 1 |
| Brakat, RM | 1 |
| Mohamed, ASED | 1 |
| Sanchez, MC | 1 |
| Krasnec, KV | 1 |
| Parra, AS | 1 |
| von Cabanlong, C | 1 |
| Gobert, GN | 1 |
| Umylny, B | 1 |
| Cupit, PM | 1 |
| Cunningham, C | 1 |
| Abd El-Aal, NF | 1 |
| Hamza, RS | 1 |
| Harb, O | 1 |
| Sobhy, MMK | 1 |
| Mahmoud, SS | 2 |
| El-Sayed, SH | 1 |
| Rizk, EMA | 1 |
| Raafat, A | 1 |
| Negm, MSI | 1 |
| Hong-Bao, L | 1 |
| Ming, S | 1 |
| Ru-Yi, L | 1 |
| Na, Z | 1 |
| Ni-Na, P | 1 |
| Li-le, L | 1 |
| Yu, H | 1 |
| Yan, M | 1 |
| Hong-Bo, W | 1 |
| Tang, X | 1 |
| Hu, W | 1 |
| Lv, Y | 1 |
| Zhang, W | 1 |
| Sun, T | 1 |
| Jiang, Y | 1 |
| Zhan, X | 1 |
| Zhou, S | 1 |
| Wangboon, C | 1 |
| Yongvanit, P | 1 |
| Loilome, W | 1 |
| Thanan, R | 1 |
| Worasith, C | 1 |
| Eamudomkarn, C | 1 |
| Chamadol, N | 1 |
| Mairiang, E | 1 |
| Sithithaworn, J | 1 |
| Saichua, P | 1 |
| Sripa, B | 1 |
| Khuntikeo, N | 1 |
| Bethony, JM | 1 |
| Sithithaworn, P | 1 |
| Ma, Z | 1 |
| Xia, D | 1 |
| Wang, L | 1 |
| Chen, Y | 2 |
| Xiong, Y | 1 |
| Issa, YA | 1 |
| El Achy, SN | 1 |
| Mady, RF | 1 |
| Abdel-Rahman, M | 1 |
| El-Sayed, M | 1 |
| El Raziky, M | 1 |
| Elsharkawy, A | 1 |
| El-Akel, W | 1 |
| Ghoneim, H | 1 |
| Khattab, H | 1 |
| Esmat, G | 1 |
| Liang, XL | 1 |
| Yuan, JY | 1 |
| Attia, YM | 2 |
| Elalkamy, EF | 1 |
| Hammam, OA | 3 |
| El-Khatib, AS | 2 |
| Xiao, Z | 1 |
| Wu, W | 1 |
| Feng, A | 1 |
| Davis, SM | 1 |
| Wiegand, RE | 1 |
| Mulama, F | 1 |
| Kareko, EI | 1 |
| Harris, R | 1 |
| Ochola, E | 1 |
| Samuels, AM | 1 |
| Rawago, F | 1 |
| Mwinzi, PM | 1 |
| Fox, LM | 1 |
| Odiere, MR | 1 |
| Won, KY | 1 |
| Schacherer, D | 1 |
| Birkenfeld, G | 1 |
| Gassiep, I | 1 |
| Clark, PJ | 1 |
| McManus, DP | 3 |
| Looke, DL | 1 |
| Elkhafif, N | 1 |
| Mansour, MT | 1 |
| Elmazar, MM | 1 |
| Abdelsalam, RM | 1 |
| Kenawy, SA | 1 |
| Elsakkar, MG | 1 |
| Eissa, MM | 1 |
| Hewedy, WA | 1 |
| Nassra, RM | 1 |
| Elatrebi, SF | 1 |
| Olveda, DU | 2 |
| Inobaya, MT | 1 |
| Olveda, RM | 3 |
| Vinluan, ML | 2 |
| Ng, SK | 2 |
| Harn, DA | 2 |
| Li, Y | 2 |
| Guevarra, JR | 2 |
| Lam, AK | 2 |
| Ross, AG | 2 |
| Inobaya, M | 1 |
| Weerakoon, K | 1 |
| Ramm, GA | 1 |
| Pinlaor, S | 1 |
| Prakobwong, S | 1 |
| Boonmars, T | 1 |
| Wongkham, C | 1 |
| Pinlaor, P | 1 |
| Hiraku, Y | 1 |
| Barros, LA | 1 |
| Costa-Silva, M | 1 |
| Biolchini, CL | 1 |
| Neves, RH | 1 |
| Machado-Silva, JR | 1 |
| Rahoud, SA | 1 |
| Mergani, A | 1 |
| Khamis, AH | 1 |
| Saeed, OK | 1 |
| Mohamed-Ali, Q | 2 |
| Dessein, AJ | 1 |
| Elwali, NE | 1 |
| Fabre, V | 1 |
| Wu, H | 1 |
| PondTor, S | 1 |
| Coutinho, H | 1 |
| Acosta, L | 1 |
| Jiz, M | 1 |
| Olveda, R | 1 |
| Cheng, L | 1 |
| White, ES | 1 |
| Jarilla, B | 1 |
| McGarvey, ST | 2 |
| Friedman, JF | 1 |
| Kurtis, JD | 1 |
| Ariza-Heredia, E | 1 |
| Razonable, RR | 1 |
| Liang, YJ | 1 |
| Luo, J | 1 |
| Yuan, Q | 1 |
| Zheng, D | 1 |
| Liu, YP | 1 |
| Shi, L | 1 |
| Zhou, Y | 1 |
| Chen, AL | 1 |
| Ren, YY | 1 |
| Sun, KY | 1 |
| Sun, Y | 1 |
| Zhang, ZS | 1 |
| Zeng, J | 1 |
| Wang, H | 1 |
| Jia, XM | 1 |
| Li, CY | 1 |
| Li, F | 1 |
| Abdel Fattah, NS | 1 |
| Ahmed, NS | 1 |
| El-Lakkany, NM | 1 |
| El-Maadawy, WH | 1 |
| Badawy, AA | 1 |
| Ain-Shoka, AA | 1 |
| Ebeid, FA | 1 |
| Said, E | 1 |
| Said, SA | 1 |
| Elkashef, WF | 1 |
| Gameil, NM | 1 |
| Ammar, EM | 1 |
| Chen, BL | 1 |
| Zhang, GY | 1 |
| Wang, SP | 1 |
| Li, Q | 1 |
| Xu, MH | 1 |
| Shen, YM | 1 |
| Yan, L | 1 |
| Gu, H | 1 |
| Li, J | 1 |
| Huang, YL | 1 |
| Mu, YB | 1 |
| Abdel-Hafeez, EH | 1 |
| Ahmad, AK | 1 |
| Abdulla, AM | 1 |
| Aabdel-Wahab, S | 1 |
| Mosalem, FA | 1 |
| Xu, H | 2 |
| Qian, H | 1 |
| Zhu, W | 1 |
| Zhang, X | 1 |
| Yan, Y | 1 |
| Mao, F | 1 |
| Wang, M | 1 |
| Xu, W | 1 |
| Standley, CJ | 1 |
| Mugisha, L | 1 |
| Adriko, M | 1 |
| Arinaitwe, M | 1 |
| Rukundo, J | 1 |
| Ajarova, L | 1 |
| Mopya, S | 1 |
| Betson, M | 1 |
| Kabatereine, NB | 2 |
| Stothard, JR | 1 |
| Xiong, LJ | 1 |
| Zhu, JF | 1 |
| Luo, DD | 1 |
| Zen, LL | 1 |
| Cai, SQ | 1 |
| Yan, SN | 1 |
| Fang, H | 1 |
| Xiang, LK | 1 |
| Singh, KP | 1 |
| Gerard, HC | 1 |
| Hudson, AP | 1 |
| Boros, DL | 1 |
| Porto, AF | 1 |
| Santos, SB | 1 |
| Alcantara, L | 1 |
| Guerreiro, JB | 1 |
| Passos, J | 1 |
| Gonzalez, T | 1 |
| Neva, F | 1 |
| Gonzalez, D | 1 |
| Ho, JL | 1 |
| Carvalho, EM | 1 |
| Dunne, DW | 1 |
| Vennervald, BJ | 1 |
| Booth, M | 1 |
| Joseph, S | 1 |
| Fitzsimmons, CM | 1 |
| Cahen, P | 1 |
| Sturrock, RF | 1 |
| Ouma, JH | 1 |
| Mwatha, JK | 1 |
| Kimani, G | 1 |
| Kariuki, HC | 1 |
| Kazibwe, F | 1 |
| Tukahebwa, E | 1 |
| Hrckova, G | 1 |
| Velebný, S | 1 |
| Daxnerová, Z | 1 |
| Solár, P | 1 |
| Andrade, ZA | 1 |
| Baptista, AP | 1 |
| Santana, TS | 1 |
| Berhe, N | 1 |
| Myrvang, B | 1 |
| Gundersen, SG | 1 |
| He, YW | 1 |
| Liu, WQ | 1 |
| Zhang, JH | 1 |
| Yang, YQ | 1 |
| Zhu, XY | 1 |
| Yang, HZ | 1 |
| Le, WJ | 1 |
| el Guiniady, MA | 1 |
| el Touny, MA | 1 |
| Abdel-Bary, MA | 1 |
| Abdel-Fatah, SA | 1 |
| Metwally, A | 1 |
| Wiest, PM | 1 |
| Wu, G | 1 |
| Zhong, S | 1 |
| Yuan, J | 1 |
| Peters, PA | 1 |
| Olds, GR | 1 |
| Montasser, MF | 1 |
| Younis, TA | 1 |
| Fahmy, IA | 1 |
| Sabry, NM | 1 |
| el-Monayerhy, MS | 1 |
| Rashad, MS | 1 |
| Morris, W | 1 |
| Knauer, CM | 1 |
| Mansy, SS | 1 |
| Yehia, HA | 1 |
| Hassan, MM | 1 |
| Hassan, EA | 1 |
| Youssef, MM | 1 |
| Hadi, AA | 1 |
| Mackenzie, CD | 1 |
| Cai, W | 1 |
| Chen, Z | 1 |
| Chen, F | 1 |
| Liu, R | 1 |
| Wang, J | 1 |
| Ricard-Blum, S | 1 |
| Hartmann, DJ | 1 |
| Grenard, P | 1 |
| Ravaoalimalala, VE | 1 |
| Boisier, P | 1 |
| Esterre, P | 1 |
| Ranque, S | 1 |
| Dessein, A | 1 |
| Cheever, AW | 1 |
| Macedonia, JG | 1 |
| Deb, S | 1 |
| Cheever, EA | 1 |
| Mosimann, JE | 1 |
| Tanaka, M | 1 |
| Doehring-Schwerdtfeger, E | 1 |
| Abdel-Rahim, IM | 1 |
| Schlake, J | 1 |
| Kardorff, R | 1 |
| Franke, D | 1 |
| Kaiser, C | 1 |
| Elsheikh, M | 1 |
| Abdalla, M | 1 |
| Schafer, P | 1 |
| Homeida, MA | 2 |
| el Tom, I | 2 |
| Nash, T | 2 |
| Bennett, JL | 3 |
| Fenwick, A | 1 |
| DeFalla, AA | 1 |
| Suliman, S | 1 |
| Kardaman, MW | 1 |
| el-Badrawy, NM | 1 |
| Hassanein, HI | 1 |
| Botros, SS | 1 |
| Nagy, FM | 1 |
| Abdallah, NM | 1 |
| Herbage, D | 1 |
| Homeida, MM | 1 |
| el Tom, IA | 1 |
| Sulaiman, SM | 1 |
| Daffalla, AA | 1 |
| el-Hawy, AM | 1 |
| Anter, A | 1 |
| Hegazi, MM | 1 |
| Massoud, A | 1 |
| Abou Tal, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on the Role of Antioxidant Micronutrients on the Reversal of Schistosomal Peri-portal Fibrosis of the Liver.[NCT01260012] | 414 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for praziquantel and Cirrhosis, Liver
| Article | Year |
|---|---|
The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis.
Topics: Animals; Anthelmintics; Humans; Liver Cirrhosis; MicroRNAs; Praziquantel; Schistosoma; Schistosomias | 2019 |
Research and control of advanced schistosomiasis japonica in China.
Topics: Animals; Anthelmintics; China; Humans; Liver Cirrhosis; Praziquantel; Schistosoma japonicum; Schisto | 2015 |
Cardiopulmonary manifestations of schistosomiasis.
Topics: Antiplatyhelmintic Agents; Heart Diseases; Humans; Hypertension, Portal; Liver Cirrhosis; Lung Disea | 1997 |
[Schistosoma mansoni schistosomiasis].
Topics: Cause of Death; Chronic Disease; Genetic Predisposition to Disease; Humans; Immunity, Innate; Liver | 2001 |
Mini-review: the ultrasonographical and serological changes and their improvement after praziquantel treatment in Schistosoma japonicum infected patients in Leyte, Philippines.
Topics: Adolescent; Adult; Atrophy; Bile Acids and Salts; Biomarkers; Humans; Hypertrophy; Liver; Liver Cirr | 1992 |
3 trials available for praziquantel and Cirrhosis, Liver
| Article | Year |
|---|---|
[Efficacy of repeated application of praziquantel in treatment of hepatic fibrosis due to schistosomiasis].
Topics: Humans; Liver; Liver Cirrhosis; Praziquantel; Schistosomiasis | 2016 |
Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure.
Topics: Absorption; Adolescent; Adult; Bilirubin; Female; Hepatomegaly; Humans; Linear Models; Liver; Liver | 1994 |
Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.
Topics: Child; Hepatomegaly; Humans; Liver; Liver Cirrhosis; Parasite Egg Count; Praziquantel; Random Alloca | 1991 |
65 other studies available for praziquantel and Cirrhosis, Liver
| Article | Year |
|---|---|
[Progress of researches on the actions of praziquantel against hepatic fibrosis].
Topics: Humans; Liver Cirrhosis; Praziquantel | 2021 |
Human umbilical cord blood mesenchymal stem cells as a potential therapy for schistosomal hepatic fibrosis: an experimental study.
Topics: Animals; Fetal Blood; Humans; Liver Cirrhosis; Mesenchymal Stem Cells; Mice; Praziquantel | 2023 |
Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice.
Topics: Animals; Antibodies, Monoclonal; Case-Control Studies; Cytokines; Eosine Yellowish-(YS); Female; Hem | 2022 |
Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models.
Topics: Adult; Animals; Clonorchis sinensis; Coinfection; Hepatitis B; Hepatitis B virus; Hepatocytes; Human | 2022 |
Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models.
Topics: Adult; Animals; Clonorchis sinensis; Coinfection; Hepatitis B; Hepatitis B virus; Hepatocytes; Human | 2022 |
Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models.
Topics: Adult; Animals; Clonorchis sinensis; Coinfection; Hepatitis B; Hepatitis B virus; Hepatocytes; Human | 2022 |
Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell models.
Topics: Adult; Animals; Clonorchis sinensis; Coinfection; Hepatitis B; Hepatitis B virus; Hepatocytes; Human | 2022 |
Praziquantel ameliorates CCl
Topics: Animals; Carbon Tetrachloride; Cell Line; Disease Models, Animal; Gene Expression; Hepatic Stellate | 2019 |
Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Child; Child, Preschool; Cross-S | 2019 |
Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
Topics: Animals; Drug Therapy, Combination; Granuloma; Liver Cirrhosis; Male; Mice; Omeprazole; Parasite Egg | 2019 |
Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models.
Topics: Animals; Antiparasitic Agents; Female; Hepatic Stellate Cells; Hepatocytes; Kupffer Cells; Liver Cir | 2020 |
Antifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice.
Topics: Animals; Anthelmintics; Anti-Infective Agents; Flavonoids; Humans; Liver; Liver Cirrhosis; Mice; Mic | 2022 |
Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
Topics: Anilides; Animals; Cercaria; Disease Models, Animal; Drug Therapy, Combination; Egypt; Female; Hedge | 2017 |
Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment.
Topics: Alanine Transaminase; Animals; Anthelmintics; Aspartate Aminotransferases; Cynara scolymus; Female; | 2017 |
Effect of praziquantel on the differential expression of mouse hepatic genes and parasite ATP binding cassette transporter gene family members during Schistosoma mansoni infection.
Topics: Animals; Anthelmintics; ATP-Binding Cassette Transporters; Disease Models, Animal; Drug Resistance; | 2017 |
Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni: A novel insight.
Topics: Actins; Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biomphalaria; Fe | 2017 |
Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
Topics: Acute Disease; Animals; Anthelmintics; Biomphalaria; Chronic Disease; Collagen; Female; Genistein; G | 2018 |
[Therapeutic effect of BILT combined with praziquantel in treatment of chronic schistosomiasis].
Topics: Case-Control Studies; Humans; Infrared Rays; Liver Cirrhosis; Praziquantel; Schistosomiasis | 2017 |
A Polysaccharide from Amusium Pleuronectes Combined with Praziquantel Treatment Ameliorates Hepatic Fibrosis in Schistosoma Japonicum-Infected Mice.
Topics: Animals; Bivalvia; Cytokines; Hyaluronoglucosaminidase; Interleukin-13; Liver Cirrhosis; Male; Mice, | 2018 |
Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Animals; Anthelmintics; Biomarkers; Cholangiocarcinoma; Chronic | 2018 |
Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice.
Topics: Actins; Animals; Collagen Type I; Collagen Type III; Female; Liver; Liver Cirrhosis; Mice; Mice, Inb | 2018 |
Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model.
Topics: Actins; Animals; Anthelmintics; Cannabinoid Receptor Antagonists; Drug Therapy, Combination; Granulo | 2019 |
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Egypt; Fem | 2013 |
Effect of Chinese herbal compound on liver fibrosis in rabbits with schistosomiasis by B-ultrasound.
Topics: Angelica sinensis; Animals; Anthelmintics; Disease Models, Animal; Herbal Medicine; Liver; Liver Cir | 2013 |
Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Benzimidazoles; Benzoates; Disease | 2013 |
[Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice].
Topics: Animals; Drug Therapy, Combination; Female; Liver Cirrhosis; Male; Mice; Oxidative Stress; Praziquan | 2013 |
Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya.
Topics: Age Distribution; Animals; Anthelmintics; Child; Child, Preschool; Cohort Studies; Cross-Sectional S | 2015 |
A Case Report--Sonomorphological Changes in Hepatosplenic Schistosomiasis.
Topics: Adult; Developing Countries; Ethiopia; Germany; Humans; Hypertension, Portal; Liver; Liver Cirrhosis | 2015 |
Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy.
Topics: Acute Disease; Animals; Anthelmintics; Anti-Inflammatory Agents; Biopsy; Chronic Disease; Hepatitis; | 2016 |
Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis.
Topics: Animals; Cell- and Tissue-Based Therapy; Humans; Liver Cirrhosis; Mesenchymal Stem Cell Transplantat | 2016 |
Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.
Topics: Animals; Anthelmintics; Histone Deacetylase Inhibitors; Liver Cirrhosis; Male; Mice; Praziquantel; S | 2016 |
Biennial versus annual treatment for schistosomiasis and its impact on liver morbidity.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Drug Administration Schedule; Female; Hum | 2017 |
Diagnosing schistosomiasis-induced liver morbidity: implications for global control.
Topics: Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Female; Humans; Hyaluronic Acid; Liver | 2017 |
Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection.
Topics: Animals; Collagen; Cricetinae; Gene Expression Profiling; Hydroxyproline; Liver; Liver Cirrhosis; Ma | 2009 |
Effect of praziquantel administration on hepatic stereology of mice infected with Schistosoma mansoni and fed a low-protein diet.
Topics: Animals; Anthelmintics; Diet, Protein-Restricted; Female; Hepatocytes; Liver; Liver Cirrhosis; Mice; | 2009 |
Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients.
Topics: Adolescent; Adult; Age Factors; Animals; Anthelmintics; Child; Child, Preschool; Disease Progression | 2010 |
Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fibrosis in human Schistosoma japonicum infection.
Topics: Adolescent; Adult; Animals; Anthelmintics; Biomarkers; Child; Cohort Studies; Collagen; Feces; Femal | 2011 |
Incidental hepatic schistosomiasis in a liver transplant recipient.
Topics: Animals; Anthelmintics; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Diseases, Parasi | 2012 |
New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum.
Topics: Alanine Transaminase; Animals; Anthelmintics; Aspartate Aminotransferases; Cells, Cultured; Female; | 2011 |
[Effect of ginsenoside Rg3 on hepatic fibrosis in murine schistosomiasis japonica].
Topics: Animals; Ginsenosides; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Phytotherapy; Praziquan | 2011 |
Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: an immunohistochemical descriptive study.
Topics: Animals; Anthelmintics; Female; Immunohistochemistry; Liver; Liver Cirrhosis; Mice; Neovascularizati | 2012 |
Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.
Topics: Animals; Drug Therapy, Combination; Hydroxyproline; Liver; Liver Cirrhosis; Liver Function Tests; Ma | 2012 |
Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice.
Topics: Animals; Anthelmintics; Disease Models, Animal; Drug Therapy, Combination; Liver Cirrhosis; Liver Di | 2012 |
The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice.
Topics: Animals; Antibodies, Neutralizing; Arteriosclerosis; Drug Therapy, Combination; Female; Granuloma; I | 2012 |
Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.
Topics: Animals; Anthelmintics; Antioxidants; Drug Therapy, Combination; Liver Cirrhosis; Male; Mice; Mice, | 2012 |
Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury.
Topics: Actins; Animals; Collagen Type III; Combined Modality Therapy; Epithelial-Mesenchymal Transition; Fe | 2012 |
Intestinal schistosomiasis in chimpanzees on Ngamba Island, Uganda: observations on liver fibrosis, schistosome genetic diversity and praziquantel treatment.
Topics: Animals; Anthelmintics; Ape Diseases; DNA Barcoding, Taxonomic; Feces; Female; Genetic Variation; Hu | 2013 |
Effects of pentoxifylline on the hepatic content of TGF-beta1 and collagen in Schistosomiasis japonica mice with liver fibrosis.
Topics: Animals; Anthelmintics; Collagen Type I; Collagen Type III; Female; Liver; Liver Cirrhosis; Mice; Pe | 2003 |
[Detection of serum transforming growth factor beta 1 in diagnosis of hepatic fibrosis in schistosomiasis and evaluation of treatment efficacy].
Topics: Anthelmintics; Humans; Liver Cirrhosis; Praziquantel; Schistosomiasis; Transforming Growth Factor be | 2003 |
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.
Topics: Animals; Anthelmintics; Body Weight; Cell Count; Cells, Cultured; Collagen; Cytokines; Female; Gene | 2004 |
HTLV-1 modifies the clinical and immunological response to schistosomiasis.
Topics: Adult; Animals; Anthelmintics; Antigens, Helminth; Cells, Cultured; Female; HTLV-I Infections; Human | 2004 |
Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda.
Topics: Animals; Anthelmintics; Cohort Studies; Drug Resistance; Female; Fisheries; Fresh Water; Humans; Liv | 2006 |
Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.
Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy, | 2006 |
Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.
Topics: Animals; Anthelmintics; Chronic Disease; Disease Models, Animal; Female; Granuloma; Humans; Liver Ci | 2006 |
Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Antibodies, Viral; Child; Ethiopia; Feces; Female; | 2008 |
Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum.
Topics: Actins; Animals; Anthelmintics; Collagen Type I; Collagen Type III; Disease Models, Animal; Hypoglyc | 2008 |
[Evaluation of praziquantel on rabbit liver cirrhosis due to schistosomiasis according to pathological changes (author's transl)].
Topics: Animals; Hepatic Artery; Isoquinolines; Liver Cirrhosis; Praziquantel; Rabbits; Radiography; Schisto | 1982 |
Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; China; Cohort Studies; Feces; Female; Hepat | 1994 |
Histopathological evidences for the antifibrogenic effect of colchicine in schistosomiasis mansoni in mice.
Topics: Animals; Colchicine; Drug Therapy, Combination; Granuloma; Liver; Liver Cirrhosis; Mice; Praziquante | 1994 |
Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis.
Topics: Animals; Drug Therapy, Combination; Egypt; Female; Liver Cirrhosis; Liver Diseases, Parasitic; Mice; | 1998 |
Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment.
Topics: Adolescent; Adult; Antiplatyhelmintic Agents; Biomarkers; Child; Female; Humans; Hyaluronic Acid; Li | 1997 |
Relationships between several markers of extracellular matrix turn-over and ultrasonography in human Schistosomiasis mansoni.
Topics: Amino Acids; Biomarkers; Collagen; E-Selectin; Extracellular Matrix; Humans; Hyaluronic Acid; Interc | 1999 |
Persistence of eggs and hepatic fibrosis after treatment of Schistosoma mansoni-infected mice.
Topics: Analysis of Variance; Animals; Benzenesulfonates; Collagen; Diphenylamine; Feces; Intestines; Isothi | 1992 |
Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Hepatomegaly; Humans; Liver Cirrhos | 1991 |
Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villages.
Topics: Adolescent; Adult; Aged; Child; Epidemiologic Methods; Humans; Liver Cirrhosis; Middle Aged; Praziqu | 1988 |
Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.
Topics: Animals; Collagen; Electrophoresis, Polyacrylamide Gel; Granuloma; Liver; Liver Cirrhosis; Male; Mic | 1988 |
Efficacy and tolerance of praziquantel in patients with Schistosoma mansoni infection and Symmers' fibrosis: a field study in the Sudan.
Topics: Drug Tolerance; Gallbladder; Humans; Liver Cirrhosis; Portal Vein; Praziquantel; Schistosomiasis man | 1988 |
Polymorphonuclear leucocyte phagocytosis in bilharzial and non bilharzial patients with enteric fevers.
Topics: Adolescent; Adult; Ampicillin; Chloramphenicol; Female; Humans; Liver Cirrhosis; Male; Middle Aged; | 1985 |